|
| Molecule | Model | Reference |
|
| Sulforaphanes (SFN) | Keap-1 purified protein | Dinkova-Kostova et al., 2002 [102] |
| Keap-1 protein (in vitro study) | Hong et al., 2005 [103] |
| Dopaminergic neurons (basal ganglia) after exposure to MPTP | Jazwa et al. 2011 [28] |
|
| Curcumin | Spinal cord primary astrocytes after exposure to H2O2 | Jiang et al., 2011 [104] |
| Primary cortical neurons after oxygen-glucose deprivation/reoxygenation (model of brain ischemia) | Wu et al., 2013 [105] |
|
| Naphthazarin | ARE-bla Hep G2 cell line and primary neuron and astrocyte cultures | Son et al., 2013 [106] |
|
| Genistein | PC12 cells after incubation with beta-amyloid peptides 25–35 | Ma et al., 2010 [127] |
| bEND.3 cells after incubation with beta-amyloid peptides 25–35 | Xi et al., 2012 [128] |
| Rat hippocampal CA1 neurons after cerebral ischemia | Wang et al., 2013 [107] |
|
| Carnosic acid | Primary cortical neurons | Satoh et al., 2008 [108] |
| SH-SY5Y cells after exposure to 6-hydroxydopamine | Chen et al., 2012 [109] |
|
| Polyphenols | | |
| Epigallocatechin 3-gallate (EGCG) | mutSOD1-transfected motoneurons | Koh et al., 2004 [110] |
| PC12 cells after exposure to paraquat | Hou et al., 2008 [111] |
| SOD1-G93A transgenic mice (model of ALS) | Koh et al., 2006 [112] |
| SOD1-G93A transgenic mice (model of ALS) | Xu et al., 2006 [113] |
| Rat immortalized neurons (H19-7) | Romeo et al., 2009 [114] |
|
| Resveratrol | Spinal cord from adult rats after hypoxic injury | Kesherwani et al., 2013 [115] |
| Dorsal root ganglionic cells after glucose-induced injury | Vincent et al., 2009 [116] |
|
